Metabolic Deregulations in Patients with Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) contributes to endocrine and metabolic complications for women worldwide. The aim of this study was to establish the usefulness of new anthropometric indices and atherogenic indices in the evaluation of metabolic disorders, in particular, glucose and insulin abnormal...

Full description

Bibliographic Details
Main Authors: Marzena Jabczyk, Justyna Nowak, Paweł Jagielski, Bartosz Hudzik, Karolina Kulik-Kupka, Aleksander Włodarczyk, Katarzyna Lar, Barbara Zubelewicz-Szkodzińska
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/13/2/302
_version_ 1797619325710893056
author Marzena Jabczyk
Justyna Nowak
Paweł Jagielski
Bartosz Hudzik
Karolina Kulik-Kupka
Aleksander Włodarczyk
Katarzyna Lar
Barbara Zubelewicz-Szkodzińska
author_facet Marzena Jabczyk
Justyna Nowak
Paweł Jagielski
Bartosz Hudzik
Karolina Kulik-Kupka
Aleksander Włodarczyk
Katarzyna Lar
Barbara Zubelewicz-Szkodzińska
author_sort Marzena Jabczyk
collection DOAJ
description Polycystic ovary syndrome (PCOS) contributes to endocrine and metabolic complications for women worldwide. The aim of this study was to establish the usefulness of new anthropometric indices and atherogenic indices in the evaluation of metabolic disorders, in particular, glucose and insulin abnormalities in the profiles of women with polycystic ovary syndrome (PCOS). In the study, a total of 49 women with PCOS aged between 18 and 39 years were recruited. All patients were tested for fasting glucose and insulin, lipid parameters, oral-glucose administration, and biochemical parameters. All of them underwent anthropometric measurements, such as BMI (body mass index), WHR (waist-to-hip ratio), WHtR (waist-to-height ratio), BAI (body adiposity index), VAI (visceral adiposity index), LAP (lipid accumulation product), BRI (body roundness index), ABSI (A body shape index), AIP (atherogenic risk of plasma), AC (atherogenic coefficient), Castelli risk index-I, Castelli risk index-II and (LCI) lipoprotein combine index, TG/HDL-C ratio, METS-IR (The metabolic score of insulin resistance), triglyceride glucose index (TyG index), triglyceride glucose-body mass index (TyG-BMI index) and triglyceride glucose-waist circumference index (TyG-WC index) were calculated. The analyzed anthropometric measurements/indices and atherogenic indices demonstrated significant correlations in PCOS women. T A strong relationship was found between fasting glucose, fasting insulin, glucose after 60 min, HOMA-IR index in the patients with PCOS. There was no significant relationship between HbA1c and other analyzed parameters and indices. Most of the analyzed anthropometric and atherogenic indices may be useful tools in evaluating metabolic disorders, and, in particular, glucose and insulin abnormalities in PCOS women.
first_indexed 2024-03-11T08:26:32Z
format Article
id doaj.art-ac6b09bfbbda423e94243f903c4e2310
institution Directory Open Access Journal
issn 2218-1989
language English
last_indexed 2024-03-11T08:26:32Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj.art-ac6b09bfbbda423e94243f903c4e23102023-11-16T22:05:41ZengMDPI AGMetabolites2218-19892023-02-0113230210.3390/metabo13020302Metabolic Deregulations in Patients with Polycystic Ovary SyndromeMarzena Jabczyk0Justyna Nowak1Paweł Jagielski2Bartosz Hudzik3Karolina Kulik-Kupka4Aleksander Włodarczyk5Katarzyna Lar6Barbara Zubelewicz-Szkodzińska7Department of Metabolic Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia, 41-900 Bytom, PolandDepartment of Metabolic Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia, 41-900 Bytom, PolandDepartment of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, 31-066 Cracow, PolandDepartment of Metabolic Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia, 41-900 Bytom, PolandDepartment of Metabolic Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia, 41-900 Bytom, PolandDistrict Hospital, 41-940 Piekary Slaskie, PolandDepartment of Metabolic Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia, 41-900 Bytom, PolandDepartment of Metabolic Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia, 41-900 Bytom, PolandPolycystic ovary syndrome (PCOS) contributes to endocrine and metabolic complications for women worldwide. The aim of this study was to establish the usefulness of new anthropometric indices and atherogenic indices in the evaluation of metabolic disorders, in particular, glucose and insulin abnormalities in the profiles of women with polycystic ovary syndrome (PCOS). In the study, a total of 49 women with PCOS aged between 18 and 39 years were recruited. All patients were tested for fasting glucose and insulin, lipid parameters, oral-glucose administration, and biochemical parameters. All of them underwent anthropometric measurements, such as BMI (body mass index), WHR (waist-to-hip ratio), WHtR (waist-to-height ratio), BAI (body adiposity index), VAI (visceral adiposity index), LAP (lipid accumulation product), BRI (body roundness index), ABSI (A body shape index), AIP (atherogenic risk of plasma), AC (atherogenic coefficient), Castelli risk index-I, Castelli risk index-II and (LCI) lipoprotein combine index, TG/HDL-C ratio, METS-IR (The metabolic score of insulin resistance), triglyceride glucose index (TyG index), triglyceride glucose-body mass index (TyG-BMI index) and triglyceride glucose-waist circumference index (TyG-WC index) were calculated. The analyzed anthropometric measurements/indices and atherogenic indices demonstrated significant correlations in PCOS women. T A strong relationship was found between fasting glucose, fasting insulin, glucose after 60 min, HOMA-IR index in the patients with PCOS. There was no significant relationship between HbA1c and other analyzed parameters and indices. Most of the analyzed anthropometric and atherogenic indices may be useful tools in evaluating metabolic disorders, and, in particular, glucose and insulin abnormalities in PCOS women.https://www.mdpi.com/2218-1989/13/2/302polycystic ovary syndromeatherogenic indicesanthropometric indicesmetabolic disorder
spellingShingle Marzena Jabczyk
Justyna Nowak
Paweł Jagielski
Bartosz Hudzik
Karolina Kulik-Kupka
Aleksander Włodarczyk
Katarzyna Lar
Barbara Zubelewicz-Szkodzińska
Metabolic Deregulations in Patients with Polycystic Ovary Syndrome
Metabolites
polycystic ovary syndrome
atherogenic indices
anthropometric indices
metabolic disorder
title Metabolic Deregulations in Patients with Polycystic Ovary Syndrome
title_full Metabolic Deregulations in Patients with Polycystic Ovary Syndrome
title_fullStr Metabolic Deregulations in Patients with Polycystic Ovary Syndrome
title_full_unstemmed Metabolic Deregulations in Patients with Polycystic Ovary Syndrome
title_short Metabolic Deregulations in Patients with Polycystic Ovary Syndrome
title_sort metabolic deregulations in patients with polycystic ovary syndrome
topic polycystic ovary syndrome
atherogenic indices
anthropometric indices
metabolic disorder
url https://www.mdpi.com/2218-1989/13/2/302
work_keys_str_mv AT marzenajabczyk metabolicderegulationsinpatientswithpolycysticovarysyndrome
AT justynanowak metabolicderegulationsinpatientswithpolycysticovarysyndrome
AT pawełjagielski metabolicderegulationsinpatientswithpolycysticovarysyndrome
AT bartoszhudzik metabolicderegulationsinpatientswithpolycysticovarysyndrome
AT karolinakulikkupka metabolicderegulationsinpatientswithpolycysticovarysyndrome
AT aleksanderwłodarczyk metabolicderegulationsinpatientswithpolycysticovarysyndrome
AT katarzynalar metabolicderegulationsinpatientswithpolycysticovarysyndrome
AT barbarazubelewiczszkodzinska metabolicderegulationsinpatientswithpolycysticovarysyndrome